Abstract

Centrosomes are the major microtubule organising centres of animal cells. Deregulation in their number occurs in cancer and was shown to trigger tumorigenesis in mice. However, the incidence, consequence and origins of this abnormality are poorly understood. Here, we screened the NCI-60 panel of human cancer cell lines to systematically analyse centriole number and structure. Our screen shows that centriole amplification is widespread in cancer cell lines and highly prevalent in aggressive breast carcinomas. Moreover, we identify another recurrent feature of cancer cells: centriole size deregulation. Further experiments demonstrate that severe centriole over-elongation can promote amplification through both centriole fragmentation and ectopic procentriole formation. Furthermore, we show that overly long centrioles form over-active centrosomes that nucleate more microtubules, a known cause of invasiveness, and perturb chromosome segregation. Our screen establishes centriole amplification and size deregulation as recurrent features of cancer cells and identifies novel causes and consequences of those abnormalities.

Details

Title
Over-elongation of centrioles in cancer promotes centriole amplification and chromosome missegregation
Author
Marteil, Gaëlle 1 ; Guerrero, Adan 2   VIAFID ORCID Logo  ; Vieira, André F 3 ; de Almeida, Bernardo P 4 ; Machado, Pedro 5 ; Mendonça, Susana 6   VIAFID ORCID Logo  ; Mesquita, Marta 7 ; Villarreal, Beth 8 ; Fonseca, Irina 1   VIAFID ORCID Logo  ; Francia, Maria E 9 ; Dores, Katharina 1 ; Martins, Nuno P 10 ; Jana, Swadhin C 1   VIAFID ORCID Logo  ; Tranfield, Erin M 11   VIAFID ORCID Logo  ; Barbosa-Morais, Nuno L 12   VIAFID ORCID Logo  ; Paredes, Joana 3 ; Pellman, David 13 ; Godinho, Susana A 14   VIAFID ORCID Logo  ; Bettencourt-Dias, Mónica 1   VIAFID ORCID Logo 

 Instituto Gulbenkian de Ciência, Oeiras, Portugal 
 Instituto Gulbenkian de Ciência, Oeiras, Portugal; Laboratorio Nacional de Microscopía Avanzada, Instituto de Biotecnología, Universidad Nacional Autónoma de México (UNAM), Cuernavaca, Morelos, Mexico 
 I3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal; IPATIMUP - Instituto de Patologia e Imunologia Molecular, Universidade do Porto, Porto, Portugal 
 Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal; Departamento de Ciências Biomédicas e Medicina, Universidade do Algarve, Faro, Portugal 
 Instituto Gulbenkian de Ciência, Oeiras, Portugal; European Molecular Biology Laboratory, Heidelberg, Germany 
 Instituto Gulbenkian de Ciência, Oeiras, Portugal; I3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal; IPATIMUP - Instituto de Patologia e Imunologia Molecular, Universidade do Porto, Porto, Portugal 
 Instituto Português de Oncologia de Lisboa, Lisbon, Portugal 
 Novartis Institutes for BioMedical Research, Boston, MA, USA 
 Instituto Gulbenkian de Ciência, Oeiras, Portugal; Institut Pasteur de Montevideo, Montevideo, Uruguay 
10  Advanced Imaging Facility, Instituto Gulbenkian de Ciência, Oeiras, Portugal 
11  Electron Microscopy Facility, Instituto Gulbenkian de Ciência, Oeiras, Portugal 
12  Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal 
13  Dana-Faber Cancer Institute, Boston, MA, USA 
14  Dana-Faber Cancer Institute, Boston, MA, USA; Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom 
Pages
1-17
Publication year
2018
Publication date
Mar 2018
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2019431725
Copyright
© 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.